The group focuses on the discovery and evaluation of phytocompounds and plant derivatives (e.g. extracts, polysaccharides, mucilage, essential oils, …) from native species and their derived nanomaterials/nanocomposites (e.g. with biosynthesized nanometals, nanopolymers, and liposomes) for generating potent bioactive microbicidal agents with minimal side-effects to constrain infectious pathogenic microorganisms (e.g. gastrointestinal, skin, and respiratory pathogens), particularly the antibiotic-resistant strains.